Clinical Trials Logo

Clinical Trial Summary

The COVID-19 epidemic has a major impact on the organization of hospital structures as a whole. Regarding the functioning of the Maternities, it was decided by the three Maternities of AP-HP. Sorbonne University of the Pitié-Salpêtrière, Trousseau and Tenon sites, from March 20, 2020 to no longer authorize visits during the stay of mothers following childbirth. This prohibition has also been extended to spouses. This measure was guided by a concern to protect both the patients, their newborn and the entire staff of the aftermath. The period surrounding a birth is a period of strong emotional impact with an incidence of postpartum depression estimated at 15% in the general population (1). The separation of women from their spouses during this period could expose them to greater psychological vulnerability. In addition, when they return home, the patients will be isolated from their relatives due to the quarantine, which is an additional risk factor for postpartum depression. The teams of the three maternity units of AP-HP. Sorbonne University have organized themselves to be able to respond to situations of mental vulnerability during their stay with the intervention of maternity psychologists and psychiatrists and child psychiatrists as is done in the treatment usual charge. In addition, anticipating situations of greater vulnerability linked to the health crisis, the Maternity teams decided to set up a follow-up of patients after their return home through a telephone interview with psychologists or student psychologists in Master at D10 - D12 and 6-8 weeks postpartum in order to identify patients at increased risk of postpartum depression and to set up appropriate management if necessary for these patients. We therefore propose through this project to describe the consequences of this separation from the spouse during the postpartum stay and then with the family after returning home within the context of quarantine by assessing the incidence of post-partum depression during this sanitary crisis. A telephone interview of all the patients will be proposed on D10 - D12 and at 6-8 weeks postpartum using specific questionnaire to calculate a score of depression. This early identification will allow the establishment of an adapted psychological follow-up.


Clinical Trial Description

The main objective of this study is to assess the emotional impact of the separation of women from their spouses following childbirth and their family isolation when returning home within the context of quarantine due to the COVID epidemic. The secondary objectives are: 1. To identify the factors of greatest vulnerability or resilience of the patients in the immediate postpartum period (6-8 weeks after delivery). 2. To evaluate the impact of quarantine on the couples (DAS-16 scale), the experience of childbirth (PPQ scale), mother-child interactions (MIBS) at D10-D12 postpartum and at 6-8 weeks postpartum. 3. Recording of all interviews allowing a qualitative study of the verbatim by the use of N-Vivo software allowing the analysis of unstructured and qualitative data. The primary endpoint will be the proportion of patients with postpartum depression defined by EPDS score >12 at D10-12 and 6-8 weeks postpartum. The EPDS relies on 10 specific items which allows the calculation of a depression score. A threshold > 12 is used in research to define the existence of depressive symptoms. For research, the score can be used as a continuous variable or in class with the threshold value 12. The secondary end points will be: 1. to study factors of greatest vulnerability or resilience of the patients will be studied: - Socio-economic data - maternal or fetal pathology during previous pregnancies - associated pregnancy pathology - Maternal psychologic history 2. to describe the impact on the couple (DAS-16 scale), the experience of childbirth (PPQ scale), mother-child interactions (MIBS): - Dyadic Adjustment scale 16 (DAS-16). Revised scale was developed to assess dyadic adjustment in marriage. - Perinatal Posttraumatic Stress Disorder Questionnaire (PPQ). This self-questionnaire makes it possible to assess the post-traumatic reactions of parents faced with the birth of a child presenting a high perinatal risk. - Mother-to-Infant Bonding Scale (MIBS): Auto questionnaire, initially developed with a view to researching disturbances in maternal feelings towards the newborn. The scores range from 0 to 24, a high score being in favor of a mother-child bond disorder. 3. Automated psycho-linguistic analysis of the interviews using the N Vivo software. This software allows an automated study of the verbatim allowing a qualitative analysis of prosody and to identify emotional profiles and thus to identify situations of anxiety, stress and depression. The study population will consist of patients with delivery of a child and: - Singleton pregnancy - Alive child without hospitalization of the child in NICU - Patient speaking and understanding French - Major patient Duration of inclusion will be 2 months The Inclusion visit will take place during hospitalization in post-partum units, signed consent informed will be collected by a qualified person (medical doctor or midwife) before inclusion. Each week, these forms will be sent to the study psychologist referent in each of the 3 Maternity units. Research follow-up visits: Scheduled telephone interview using the assessment scales described above on D10-D12 and 6-8 weeks postpartum with a psychologist or an M2 psychology student under the responsibility of a maternity psychologist. A reminder system is provided by sending an SMS / email 48 hours before the scheduled call. In the event of a missed call, a re-call is scheduled on the same day or the next day (the SMS / email sent to patients indicates this reminder mode in the event of unavailability during the first call). During this call, a semi-structured interview is carried out with EPDS score, DAS-16 scale, PPQ and MIBS questionnaire, and a recording for analysis of unstructured and qualitative data. When EPDS score> 12: proposal for psychological follow-up in accordance with current standard of care in the event of postpartum depression. For scores <12, the possibility of a further interview with a psychologist, apart from the study, is formulated. Telephone interview at 6-8 weeks with psychologist including, as previously described, a semi-structured interview with EPDS score, DAS-16 scale and MIBS questionnaire and a recording for analysis of unstructured and qualitative data When EPDS score> 12: proposal for psychological follow-up in accordance with current standard of care in the event of postpartum depression. For scores <12, the possibility of a further interview with a psychologist is formulated. The patients were informed of the recording of the calls. In case of refusal, the calls are not recorded and only the semi-structured interview is carried out with EPDS score and DAS-16 scale and PPQ and MIBS questionnaire. Sample size justification The inclusion of 452 women will allow to detect at least a 5 points change in the proportion of postpartum depression during COVID pandemic period compared to the expected/usual proportion of 15% (15 vs. 20%) with 80% of power, considering two-sided alpha risk of 5% and 5% of dropout. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04366817
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase N/A
Start date April 27, 2020
Completion date February 17, 2021

See also
  Status Clinical Trial Phase
Completed NCT03665038 - A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD) Phase 3
Recruiting NCT06042972 - Risk of Maternal Depression From 1 Year to 4 Years Postpartum in Yvelines
Completed NCT04813341 - Effectiveness of Mat Pilates and Aerobic Training on Fatigue and Depression N/A
Terminated NCT04998565 - Add-on Effectiveness of EA or TENS in Early Postpartum Breast Engorgement N/A
Completed NCT04135612 - The Impact of a Daily Smartphone-based Communication Among Postpartum Women on Breastfeeding Rates N/A
Recruiting NCT05595486 - Baby2Home (B2H) Mobile Health Application N/A
Not yet recruiting NCT04516668 - Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum Depression
Completed NCT05215028 - Optimization of Mother-child Dyad Follow-up by a Multidomain Application: Real-world Cross Sectional Study
Recruiting NCT04129476 - Effect of a Cooperative Education Program Based on Precede-Proceed Model During Pregnancy on Postpartum Depression N/A
Recruiting NCT04193462 - Relationship-Based Intervention for Post-Partum Depression N/A
Completed NCT03638687 - Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers
Active, not recruiting NCT03052374 - Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and Their Infants ("VID-KIDS") N/A
Active, not recruiting NCT04940585 - ROSE in Sunset Park N/A
Terminated NCT04011592 - Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression Phase 2
Recruiting NCT05887115 - Nurse Family Partnership for Women With Previous Live Births N/A
Completed NCT04818047 - Adaptation and Pilot Testing of Web and Mobile Interface for the VID-KIDS Intervention N/A
Not yet recruiting NCT05643898 - "Mamá, te Entiendo" App-based Intervention for Reducing Depressive Symptoms in Postpartum Women N/A
Terminated NCT04264520 - Initial Intervention Efficacy for an Online PTSD Intervention for Pregnant Women N/A
Recruiting NCT04845347 - A Wearable Morning Light Treatment for Postpartum Depression N/A
Enrolling by invitation NCT05186272 - mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression Phase 3